Analysis of JAK Pathway Activation in Drosophila
Analysis of JAK Pathway Activation in Drosophila
批准号:
0091535
负责人:
Douglas Harrison
金额:
$31.5万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2004-03-31
中文摘要
细胞间的通讯是多细胞生物体正常发育和维持的重要因素。作为信号的分子的数量是巨大的,然而细胞对信号做出反应的机制受到更多的限制。随着重新利用细胞内信号级联启动适当的细胞反应,出现了有限数量的信号通路。这项研究的长期目标是阐明细胞通讯的机制,并了解不同的信号是如何整合和解释来调节发育事件的。从黏菌到人类的生物体中都发现了一个保守的细胞内级联信号通路,即Janus Kinase(JAK)信号通路。在脊椎动物中,JAK信号是细胞对多种细胞因子和生长因子做出反应的主要机制。果蝇被选择来研究JAK信号,因为它使用JAK途径的方式与人类相同,但可以接受遗传和发育操作。果蝇体内唯一已知的JAK信号激活剂是未配对蛋白(UPD)。以前资助的研究(IBN-9723944)侧重于UPD的分子和生化特征。UPD蛋白与以前发现的哺乳动物蛋白没有明显的相似之处,但与密切相关的果蝇物种的蛋白质相似。在这两种果蝇中都发现了Om(1E)和upd基因。此外,最近公布的果蝇基因组序列已经确定了另外两个与UPD同源的较不保守的预测蛋白质。将研究这三个新基因的功能,以及这些基因与UPD和彼此之间的关系。了解果蝇JAK途径激活的分子和机制可能会为许多多细胞生物体的发育信号提供深入的认识。这项研究的主要目标是:(1)从分子、生化和表型上鉴定果蝇Om(1E)基因,(2)确定Om(1E)和UPD之间的功能关系,(3)从分子和表型上鉴定另外两种与UPD同源的蛋白质,以及(4)利用遗传筛选鉴定JAK信号转导的其他成分和相关途径。
英文摘要
0091535HarrisonCommunication between cells is a vital factor in proper development and maintenance of multicellular organisms. The number of molecules that serve as signals is enormous, yet the mechanisms by which cells can respond to signals are much more restricted. A finite number of signaling pathways have emerged as reutilized intracellular signaling cascades that initiate appropriate cellular responses. The long term objectives of this research are to elucidate mechanisms of cellular communication and to understand how different signals are integrated and interpreted to regulate developmental events. One conserved intracellular cascade that has been found in organisms from slime mold to human is the Janus kinase (JAK) signaling pathway. In vertebrates, JAK signaling is the primary mechanism for response of cells to a wide array of cytokines and growth factors. The fruit fly, Drosophila melanogaster, was chosen to study JAK signaling because it uses the JAK pathway in the same manner as humans, yet is amenable to genetic and developmental manipulation. The only known activator of JAK signaling in Drosophila is the Unpaired (Upd) protein. Previously funded research (IBN-9723944) focused on the molecular and biochemical characterization of upd. The Upd protein bears no recognizable similarity to previously identified mammalian proteins, but is similar to a protein from a closely related fruit fly species, Drosophila ananassae. Both Om(1E) and updgenes are found in both of these Drosophila species. Furthermore, the recent release of the Drosophila genome sequence has identified two additional, less conserved predicted proteins that have homology to Upd. The functions of these three new genes will be investigated, as well as the relationships of these genes to upd and to one another. Understanding of the molecules and mechanisms of JAK pathway activation in Drosophila will likely provide insights into developmental signaling in many multicellular organisms. The primary goals of this research are to: (1) characterize, molecularly, biochemically, and phenotypically, the Drosophila melanogaster Om(1E) gene, (2) determine the functional relationships between Om(1E) and upd, (3) characterize, molecularly and phenotypically, two other proteins with homology to Upd, and (4) identify additional components of JAK signaling and related pathways using genetic screens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Unpaired3 in Janus kinase signaling
-
批准号:0920432
-
项目类别:Standard Grant
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:Douglas Harrison
-
依托单位:
Follicular Patterning Directed By Janus Kinase Signaling
-
批准号:0318776
-
项目类别:Continuing Grant
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Douglas Harrison
-
依托单位:
Genetic Analysis of JAK Signaling in Drosophila
-
批准号:9723944
-
项目类别:Standard Grant
-
资助金额:$31.0万
-
财政年份:1997
-
负责人:Douglas Harrison
-
依托单位:
国内基金
海外基金
登录
查看更多内容
JAK抑制剂靶向调控免疫-循环网络治疗医美注射填充术后异物肉芽肿的机制探索与策略创新
-
批准号:2026JJ30206
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁建云
-
依托单位:
基于ACO2-JAK/STAT3信号轴探讨芫荽及其活性成分改善动脉粥样硬化的药理机制研究
-
批准号:2026JJ82274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:侯凯
-
依托单位:
SIRT6通过去乙酰化修饰调控JAK2/STAT1信号通路介导细胞焦亡途径促进脊髓损伤进展的分子机制研究
-
批准号:2026JJ81836
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈朝晖
-
依托单位:
JAK2/NAT10促进结直肠癌进展作用机制及靶向干预策略
-
批准号:2026JJ30128
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭彦茜
-
依托单位:
黄芪多糖调控JAK2/STAT3信号通路抵抗PD-L1介导的卵巢癌细胞免疫逃逸研究
-
批准号:JCZRLH202600817
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
益气活血方调控雪旺细胞外泌体/JAK2/STAT3通路介导巨噬细胞极化改善糖尿病足溃疡的作用机制研究
-
批准号:2026JJ80487
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:于洪海
-
依托单位:
基于JAK-STAT通路调控的铁死亡探讨“补气化痰解郁” 针药合用对乳腺癌并病抑郁的作用机制
-
批准号:JCZRLH202600823
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
NUP155-JAK2/STAT3-CD36轴协同调控线粒体凋亡与铁死亡逆转MSS型结直肠癌免疫耐受的机制研究
-
批准号:JCZRLH202601043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于苦参碱介导JAK2通路改善胆汁酸代谢减轻炎症性肠病炎症和氧化应激的机制研究
-
批准号:2026JJ80627
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈学亮
-
依托单位:
乌司他丁靶向抑制HDAC1通过SOCS1/JAK2/STAT3 轴调控小胶质细胞极化来减轻局灶性脑缺血再灌注损伤的机制研究
-
批准号:2026JJ81821
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈晓曦
-
依托单位: